Initial Statement of Beneficial Ownership (3)
March 22 2018 - 4:51PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
MESSINA RICHARD
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/19/2018
|
3. Issuer Name
and
Ticker or Trading Symbol
JUNIPER PHARMACEUTICALS INC [JNP]
|
(Last)
(First)
(Middle)
C/O JUNIPER PHARMACEUTICALS INC., 33 ARCH STREET SUITE 3110
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
BOSTON, MA 02110
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
8032
|
D
|
|
Common Stock
|
250
|
I
|
See Footnote
(1)
|
Common Stock
|
250
|
I
|
See Footnote
(2)
|
Common Stock
|
250
|
I
|
See Footnote
(3)
|
Common Stock
|
8000
|
I
|
See Footnote
(4)
|
Common Stock
|
9700
|
I
|
See Footnote
(5)
|
Common Stock
|
41000
|
I
|
See Footnote
(6)
|
Common Stock
|
14500
|
I
|
See Footnote
(7)
|
Common Stock
|
2001
|
I
|
See Footnote
(8)
|
Common Stock
|
28000
|
I
|
See Footnote
(9)
|
Common Stock
|
6250
|
I
|
See Footnote
(10)
|
Common Stock
|
875
|
I
|
See Footnote
(11)
|
Common Stock
|
100000
|
I
|
See Footnote
(12)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(1)
|
shares held by Richard Messina CF Jacqueline Messina UTMA
|
(2)
|
shares held by Richard Messina CF Carolyn Messina UTMA
|
(3)
|
shares held by Richard Messina CF Madeline Messina UTMA
|
(4)
|
Shares held by Equity TR Co TTEE FBO Pamela Brocious SEP
|
(5)
|
Shares held by Steve A. Sanders and Partners
|
(6)
|
Shares held by Citistaffing LLC Profit Sharing
|
(7)
|
Shares held by Summit Capital Associates.
|
(8)
|
Shares held by Benchmark Pellinore Group
|
(9)
|
Shares held by SCA Retirement Plan DTD 1/1/91
|
(10)
|
Shares held by Pamela Brocious M/P PEN PL
|
(11)
|
Shares held by SCA Money Purchase Plan DTD 1/1/94 Attn Richard Messina
|
(12)
|
Shares held by The Benchmark Company LLC - Investment Purposes
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
MESSINA RICHARD
C/O JUNIPER PHARMACEUTICALS INC.
33 ARCH STREET SUITE 3110
BOSTON, MA 02110
|
X
|
|
|
|
Signatures
|
/s/ Jeffrey Young, Attorney-in-Fact
|
|
3/22/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Juniper Pharmaceuticals, Inc. (NASDAQ:JNP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Juniper Pharmaceuticals, Inc. (NASDAQ:JNP)
Historical Stock Chart
From Sep 2023 to Sep 2024